Income Statement Coral Laboratories Limited

Stocks

CORALAB6

INE683E01017

Pharmaceuticals

Market Closed - Bombay S.E. 06:02:27 2026-10-05 EDT			5-day change	1st Jan Change
561.90 ^INR	+2.42%		-0.15%	+28.14%

08-14	Coral Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-30	Coral Laboratories Limited Recommends Final Dividend for the Financial Year 2025-2026	CI

a2b1c988bfd3.K3m1xFyqA4HSrjqTdp4HwBjRSOxfdrJBLkp_24kGN2s.ak7atw-aTcK4lk_aF9pjok-LK7ZmMdgzVA8d6L5pRRJuTOeGG99W7-DGXQ

Published financial data: CORAL LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Revenues	756M	781M	837M	1.15B	859M
Other Revenues, Total	-	-	-	-	-
Total Revenues	756M	781M	837M	1.15B	859M
Cost of Goods Sold, Total	408M	468M	381M	541M	366M
Gross Profit	348M	313M	456M	609M	493M
Selling General & Admin Expenses, Total	118M	113M	121M	151M	163M
Depreciation & Amortization - (IS)	19.91M	21.8M	19.76M	20.11M	21.37M
Other Operating Expenses	145M	158M	168M	192M	174M
Other Operating Expenses, Total	282M	293M	309M	363M	358M
Operating Income	65.97M	20.73M	146M	246M	135M
Interest Expense, Total	-1.41M	-3.38M	-2K	-976K	-1.71M
Interest And Investment Income	17.49M	17.87M	33.56M	48.39M	48.34M
Net Interest Expenses	16.08M	14.49M	33.56M	47.41M	46.63M
Currency Exchange Gains (Loss)	13.83M	32.35M	9.51M	14.88M	24.4M
Other Non Operating Income (Expenses)	13.08M	14.31M	19.78M	24.15M	22.39M
EBT, Excl. Unusual Items	109M	81.88M	209M	332M	228M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Insurance Settlements	-	-	-	-	-
Other Unusual Items	9.59M	381K	-1.64M	-7.7M	3.12M
EBT, Incl. Unusual Items	119M	82.26M	207M	325M	231M
Income Tax Expense	28.1M	17.81M	49.43M	83.15M	67.34M
Earnings From Continuing Operations	90.46M	64.45M	158M	242M	164M
Net Income to Company	90.46M	64.45M	158M	242M	164M
Net Income - (IS)	90.46M	64.45M	158M	242M	164M
Net Income to Common Incl Extra Items	90.46M	64.45M	158M	242M	164M
Net Income to Common Excl. Extra Items	90.46M	64.45M	158M	242M	164M
Per Share Items
Net EPS - Basic	25.32	18.04	44.19	67.61	45.85
Basic EPS - Continuing Operations	25.32	18.04	44.19	67.61	45.85
Basic Weighted Average Shares Outstanding	3.57M	3.57M	3.57M	3.57M	3.57M
Net EPS - Diluted	25.32	18.04	44.19	67.61	45.85
Diluted EPS - Continuing Operations	25.32	18.04	44.19	67.61	45.85
Diluted Weighted Average Shares Outstanding	3.57M	3.57M	3.57M	3.57M	3.57M
Normalized Basic EPS	19.06	14.32	36.56	58.15	39.89
Normalized Diluted EPS	19.06	14.32	36.56	58.15	39.89
Dividend Per Share	-	-	2	1.5	2
Payout Ratio	-	-	-	2.96	3.27
Supplemental Items
EBITDA	85.74M	42.45M	166M	266M	156M
EBITA	65.97M	20.73M	146M	246M	135M
EBIT	65.97M	20.73M	146M	246M	135M
EBITDAR	-	-	-	-	-
Total Revenues (As Reported)	804M	850M	903M	1.24B	958M
Effective Tax Rate - (Ratio)	23.7	21.65	23.84	25.61	29.13
Total Current Taxes	27.5M	18.2M	49.09M	83.3M	57.8M
Total Deferred Taxes	600K	-393K	338K	-154K	9.54M
Normalized Net Income	68.1M	51.18M	131M	208M	143M
Non-Cash Pension Expense	295K	285K	293K	311K	341K
Supplemental Operating Expense Items
Advertising Expense	5.24M	1.6M	9.41M	4.09M	3.37M
Selling and Marketing Expenses	5.24M	1.6M	9.41M	4.09M	3.37M
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Maintenance & Repair Expenses, Total	10.86M	10.31M	8.58M	10.46M	10.71M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Assets
Cash And Equivalents	25.06M	61.3M	20.71M	34.06M	13.71M
Short Term Investments	21.19M	12.38M	13.23M	12.03M	12.32M
Trading Asset Securities, Total	196M	226M	244M	263M	281M
Total Cash And Short Term Investments	243M	300M	278M	309M	307M
Accounts Receivable, Total	381M	234M	282M	336M	294M
Other Receivables	57K	-	-	-	-
Notes Receivable	1.54M	2.02M	1.95M	2.34M	2.35M
Total Receivables	383M	236M	284M	339M	297M
Inventory	184M	125M	152M	98.71M	205M
Prepaid Expenses	1.97M	859K	867K	749K	1.18M
Other Current Assets, Total	497M	573M	824M	1.02B	960M
Total Current Assets	1.31B	1.24B	1.54B	1.77B	1.77B
Gross Property Plant And Equipment	472M	492M	499M	527M	707M
Accumulated Depreciation	-227M	-249M	-266M	-285M	-275M
Net Property Plant And Equipment	245M	243M	233M	242M	432M
Long-term Investments	244M	174M	240M	248M	168M
Other Intangibles, Total	185K	177K	632K	674K	563K
Loans Receivable Long-Term	3.5M	3.5M	3.5M	3.5M	3.5M
Other Long-Term Assets, Total	98.04M	87.46M	41.04M	34.74M	32.92M
Total Assets	1.9B	1.74B	2.06B	2.29B	2.41B
Liabilities
Accounts Payable, Total	87.98M	41.34M	132M	66.23M	100M
Accrued Expenses, Total	13.65M	18.72M	13.66M	17.01M	17.33M
Short-term Borrowings	60.39M	-	-	35.59M	43.27M
Current Income Taxes Payable	27.5M	18.2M	49.09M	83.3M	57.8M
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	65.66M	40.35M	53.84M	47.46M	54.46M
Total Current Liabilities	255M	119M	249M	250M	273M
Pension & Other Post Retirement Benefits	3.45M	3.46M	3.81M	4.09M	3.9M
Deferred Tax Liability Non Current	25.75M	25.36M	25.7M	25.54M	35.08M
Other Non Current Liabilities	54.06M	48.05M	3.34M	3.38M	3.43M
Total Liabilities	338M	195M	282M	283M	315M
Common Stock, Total	35.73M	35.73M	35.73M	35.73M	35.73M
Retained Earnings	1.29B	1.36B	1.52B	1.75B	1.91B
Comprehensive Income and Other	230M	153M	223M	225M	146M
Total Common Equity	1.56B	1.55B	1.77B	2.01B	2.09B
Total Equity	1.56B	1.55B	1.77B	2.01B	2.09B
Total Liabilities And Equity	1.9B	1.74B	2.06B	2.29B	2.41B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.57M	3.57M	3.57M	3.57M	3.57M
ECS Total Common Shares Outstanding	3.57M	3.57M	3.57M	3.57M	3.57M
Book Value / Share	436.81	433.29	496.83	563.19	585.33
Tangible Book Value	1.56B	1.55B	1.77B	2.01B	2.09B
Tangible Book Value Per Share	436.75	433.24	496.65	563	585.17
Total Debt	60.39M	0	0	35.59M	43.27M
Net Debt	-182M	-300M	-278M	-274M	-264M
Debt Equivalent of Unfunded Proj. Benefit Obligation	4.4M	4.46M	4.76M	5.02M	5.24M
Debt Equivalent Oper. Leases	-	-	-	-	-
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	110M	87.1M	82.91M	64.08M	101M
Inventories - Work In Process, Total	15.83M	8.52M	31.77M	9.86M	28.59M
Inventories - Finished Goods, Total	48.79M	19.75M	27.8M	16.56M	67.56M
Inventories - Others	9.28M	9.67M	9.09M	8.2M	7.82M
Land - (BS)	-	-	-	-	-
Buildings, Total	123M	136M	136M	138M	289M
Machinery, Total	332M	356M	363M	365M	418M
Full Time Employees	168	109	142	197	149

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Net Income	90.46M	64.45M	158M	242M	164M
Depreciation & Amortization - CF	19.78M	21.72M	19.71M	19.97M	21.26M
Depreciation & Amortization, Total	19.78M	21.72M	19.71M	19.97M	21.26M
Amortization of Deferred Charges, Total - (CF)	131K	84K	45K	136K	111K
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-1.36M	-3.73M	-	-
Other Operating Activities, Total	-45.16M	-18.88M	-33.47M	-32.68M	-56.15M
Change In Accounts Receivable	10.45M	147M	-47.72M	-54.49M	42.12M
Change In Inventories	33.13M	58.58M	-26.53M	52.86M	-107M
Change In Accounts Payable	-55.7M	-51.13M	90.28M	-66.17M	34.01M
Change in Other Net Operating Assets	7.75M	-93.75M	-211M	-173M	57.59M
Cash from Operations	60.84M	127M	-54.65M	-12.22M	156M
Capital Expenditure	-55.48M	-19.45M	-9.91M	-29.45M	-235M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-20.33M	-17.31M	1.82M	-4.29M	-96.44M
Other Investing Activities, Total	15.3M	10.62M	22.08M	32.22M	155M
Cash from Investing	-60.51M	-26.15M	13.99M	-1.52M	-177M
Short Term Debt Issued, Total	2.9M	-	68K	35.2M	7.67M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	2.9M	-	68K	35.2M	7.67M
Short Term Debt Repaid, Total	-	-60.88M	-	-	-
Total Debt Repaid	-	-60.88M	-	-	-
Common Dividends Paid	-	-	-	-7.14M	-5.36M
Common & Preferred Stock Dividends Paid	-	-	-	-7.14M	-5.36M
Other Financing Activities, Total	-1.41M	-3.38M	-2K	-976K	-1.72M
Cash from Financing	1.49M	-64.26M	66K	27.08M	598K
Miscellaneous Cash Flow Adjustments	-	-1K	-	-	-
Net Change in Cash	1.82M	36.24M	-40.59M	13.34M	-20.35M
Supplemental Items
Cash Interest Paid	1.41M	3.38M	2K	976K	1.71M
Cash Income Tax Paid (Refund)	43.69M	19.69M	48.85M	73.32M	71.2M
Levered Free Cash Flow	-6.81M	67.1M	-93.83M	-86.53M	-122M
Unlevered Free Cash Flow	-5.93M	69.22M	-93.83M	-85.92M	-121M
Change In Net Working Capital	11.58M	-53.91M	195M	230M	-9.13M
Net Debt Issued / Repaid	2.9M	-60.88M	68K	35.2M	7.67M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Profitability
Return on Assets	2.31	0.71	4.81	7.07	3.58
Return on Total Capital	2.7	0.82	5.5	8.04	4.02
Return On Equity %	6.18	4.15	9.5	12.76	7.98
Return on Common Equity	6.18	4.15	9.5	12.76	7.98
Margin Analysis
Gross Profit Margin %	46.03	40.13	54.45	52.99	57.38
SG&A Margin	15.54	14.46	14.51	13.17	18.92
EBITDA Margin %	11.34	5.43	19.82	23.12	18.15
EBITA Margin %	8.72	2.65	17.46	21.39	15.67
EBIT Margin %	8.72	2.65	17.46	21.39	15.67
Income From Continuing Operations Margin %	11.96	8.25	18.87	21	19.07
Net Income Margin %	11.96	8.25	18.87	21	19.07
Net Avail. For Common Margin %	11.96	8.25	18.87	21	19.07
Normalized Net Income Margin	9.01	6.55	15.61	18.06	16.59
Levered Free Cash Flow Margin	-0.9	8.59	-11.22	-7.52	-14.17
Unlevered Free Cash Flow Margin	-0.78	8.86	-11.22	-7.47	-14.05
Asset Turnover
Asset Turnover	0.42	0.43	0.44	0.53	0.37
Fixed Assets Turnover	3.33	3.2	3.52	4.84	2.55
Receivables Turnover (Average Receivables)	1.96	2.54	3.24	3.72	2.72
Inventory Turnover (Average Inventory)	2.04	3.03	2.76	4.32	2.41
Short Term Liquidity
Current Ratio	5.13	10.42	6.18	7.07	6.48
Quick Ratio	2.44	4.5	2.25	2.59	2.2
Operating Cash Flow to Current Liabilities	0.24	1.07	-0.22	-0.05	0.57
Days Sales Outstanding (Average Receivables)	186.51	143.76	112.9	98.13	134
Days Outstanding Inventory (Average Inventory)	179.07	120.44	132.85	84.48	151.57
Average Days Payable Outstanding	114.75	57.68	78.36	74.31	64.28
Cash Conversion Cycle (Average Days)	250.84	206.51	167.39	108.3	221.29
Long Term Solvency
Total Debt/Equity	3.87	-	-	1.77	2.07
Total Debt / Total Capital	3.73	-	-	1.74	2.03
Total Liabilities / Total Assets	17.82	11.21	13.7	12.31	13.11
EBIT / Interest Expense	46.75	6.12	73.06K	252	78.54
EBITDA / Interest Expense	60.77	12.54	82.91K	272.46	90.94
(EBITDA - Capex) / Interest Expense	21.45	6.79	77.96K	242.29	-46.35
Total Debt / EBITDA	0.7	-	-	0.13	0.28
Net Debt / EBITDA	-2.13	-7.07	-1.68	-1.03	-1.69
Total Debt / (EBITDA - Capex)	2	-	-	0.15	-0.54
Net Debt / (EBITDA - Capex)	-6.02	-13.05	-1.78	-1.16	3.32
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-21.7	3.32	7.09	37.47	-25.31
Gross Profit, 1 Yr. Growth %	-21.55	-9.94	45.34	33.77	-19.11
EBITDA, 1 Yr. Growth %	-47.23	-50.5	290.66	60.37	-41.39
EBITA, 1 Yr. Growth %	-53.81	-68.58	604.86	68.33	-45.27
EBIT, 1 Yr. Growth %	-53.81	-68.58	604.86	68.33	-45.27
Earnings From Cont. Operations, 1 Yr. Growth %	-33.26	-28.75	144.97	52.99	-32.18
Net Income, 1 Yr. Growth %	-33.26	-28.75	144.97	52.99	-32.18
Normalized Net Income, 1 Yr. Growth %	-38.07	-24.86	155.2	59.08	-31.4
Diluted EPS Before Extra, 1 Yr. Growth %	-33.26	-28.75	144.97	52.99	-32.18
Accounts Receivable, 1 Yr. Growth %	-2.67	-38.55	20.38	19.33	-12.52
Inventory, 1 Yr. Growth %	-15.28	-31.9	21.22	-34.87	107.98
Net Property, Plant and Equip., 1 Yr. Growth %	17.15	-0.87	-4.15	4.09	78.38
Total Assets, 1 Yr. Growth %	13.34	-8.19	17.97	11.56	4.88
Tangible Book Value, 1 Yr. Growth %	14.21	-0.8	14.64	13.36	3.94
Common Equity, 1 Yr. Growth %	14.2	-0.8	14.66	13.36	3.93
Cash From Operations, 1 Yr. Growth %	553.53	108.18	-143.15	-77.63	-1.38K
Capital Expenditures, 1 Yr. Growth %	307.9	-64.94	-49.06	197.17	699.04
Levered Free Cash Flow, 1 Yr. Growth %	-18.09	-1.09K	-239.83	-7.78	40.72
Unlevered Free Cash Flow, 1 Yr. Growth %	-26.34	-1.27K	-235.55	-8.43	40.47
Dividend Per Share, 1 Yr. Growth %	-	-	-	-25	33.33
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.5	-10.06	5.19	21.33	1.33
Gross Profit, 2 Yr. CAGR %	9.83	-15.95	14.41	39.43	4.02
EBITDA, 2 Yr. CAGR %	22.65	-48.89	39.06	150.3	-3.05
EBITA, 2 Yr. CAGR %	33.3	-61.9	48.82	244.46	-4.02
EBIT, 2 Yr. CAGR %	33.3	-61.9	48.82	244.46	-4.02
Earnings From Cont. Operations, 2 Yr. CAGR %	12.63	-31.04	32.12	93.59	1.86
Net Income, 2 Yr. CAGR %	12.63	-31.04	32.12	93.59	1.86
Normalized Net Income, 2 Yr. CAGR %	9.32	-31.78	38.48	101.48	4.46
Diluted EPS Before Extra, 2 Yr. CAGR %	12.63	-31.04	32.12	93.59	1.86
Accounts Receivable, 2 Yr. CAGR %	5.25	-22.66	-13.99	19.85	2.17
Inventory, 2 Yr. CAGR %	-2.46	-24.05	-9.15	-11.15	16.38
Net Property, Plant and Equip., 2 Yr. CAGR %	6.76	7.77	-2.52	-0.12	36.26
Total Assets, 2 Yr. CAGR %	14.72	2.01	4.07	14.72	8.17
Tangible Book Value, 2 Yr. CAGR %	16.17	6.44	6.64	14	8.55
Common Equity, 2 Yr. CAGR %	16.15	6.44	6.65	14.01	8.54
Cash From Operations, 2 Yr. CAGR %	25.5	268.85	-5.22	-68.93	69.04
Capital Expenditures, 2 Yr. CAGR %	100.53	19.59	-57.74	23.04	387.29
Levered Free Cash Flow, 2 Yr. CAGR %	-71.8	184.12	271.22	13.56	13.92
Unlevered Free Cash Flow, 2 Yr. CAGR %	-73.63	193.29	297.88	11.41	13.41
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-6.02	3.44	-4.67	15	3.22
Gross Profit, 3 Yr. CAGR %	-0.75	2.8	0.88	20.53	16.29
EBITDA, 3 Yr. CAGR %	-12.03	-9.36	0.68	45.83	54.28
EBITA, 3 Yr. CAGR %	-14.92	-17.66	0.76	55.06	86.57
EBIT, 3 Yr. CAGR %	-14.92	-17.66	0.76	55.06	86.57
Earnings From Cont. Operations, 3 Yr. CAGR %	-3.98	-3.31	5.22	38.74	36.47
Net Income, 3 Yr. CAGR %	-3.98	-3.31	5.22	38.74	36.47
Normalized Net Income, 3 Yr. CAGR %	-11.1	-3.52	5.9	45.03	40.69
Diluted EPS Before Extra, 3 Yr. CAGR %	-3.98	-3.31	5.22	38.74	36.47
Accounts Receivable, 3 Yr. CAGR %	7.92	-12.03	-10.37	-4.08	7.91
Inventory, 3 Yr. CAGR %	4.32	-13.47	-11.24	-18.69	17.97
Net Property, Plant and Equip., 3 Yr. CAGR %	3.47	4.15	3.64	-0.37	21.18
Total Assets, 3 Yr. CAGR %	11.83	6.51	7.08	6.51	11.34
Tangible Book Value, 3 Yr. CAGR %	11.12	10.21	9.1	8.83	10.54
Common Equity, 3 Yr. CAGR %	11.11	10.2	9.11	8.84	10.54
Cash From Operations, 3 Yr. CAGR %	90.3	48.56	80.39	-41.43	7.23
Capital Expenditures, 3 Yr. CAGR %	25.36	12.13	-10.02	-19.03	129.55
Levered Free Cash Flow, 3 Yr. CAGR %	-52.22	-7.79	124.32	133.36	21.97
Unlevered Free Cash Flow, 3 Yr. CAGR %	-54.34	-6.7	126.76	143.83	20.36
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-3.51	-3.32	-1.69	10.26	-2.31
Gross Profit, 5 Yr. CAGR %	-5.15	-3.56	5.05	16.13	2.13
EBITDA, 5 Yr. CAGR %	-18.22	-22.78	5.66	36.07	-0.83
EBITA, 5 Yr. CAGR %	-21.34	-31.67	6.41	45.96	-1.18
EBIT, 5 Yr. CAGR %	-21.34	-31.67	6.41	45.96	-1.18
Earnings From Cont. Operations, 5 Yr. CAGR %	-11.11	-12.33	9.1	27.64	3.86
Net Income, 5 Yr. CAGR %	-11.11	-12.33	9.1	27.64	3.86
Normalized Net Income, 5 Yr. CAGR %	-15.26	-14.62	6.15	29.53	5.32
Diluted EPS Before Extra, 5 Yr. CAGR %	-11.11	-12.33	9.1	27.64	3.86
Accounts Receivable, 5 Yr. CAGR %	4.46	-5.82	-1.45	-0.45	-5.55
Inventory, 5 Yr. CAGR %	-2.4	-6.56	-1.29	-12.55	-1.08
Net Property, Plant and Equip., 5 Yr. CAGR %	7.23	2.78	1.03	2.42	15.63
Total Assets, 5 Yr. CAGR %	7.69	4.46	8.66	9.72	7.51
Tangible Book Value, 5 Yr. CAGR %	7.42	5.89	9.31	11.71	8.88
Common Equity, 5 Yr. CAGR %	7.41	5.88	9.3	11.71	8.88
Cash From Operations, 5 Yr. CAGR %	-10.8	-1.22	43.99	-20.56	75.76
Capital Expenditures, 5 Yr. CAGR %	22.53	-16.27	-18.85	16.37	76.85
Levered Free Cash Flow, 5 Yr. CAGR %	-16.98	0.74	8.49	0.22	71.06
Unlevered Free Cash Flow, 5 Yr. CAGR %	-19.05	1.3	8.54	0.16	71.87
Dividend Per Share, 5 Yr. CAGR %	-	-	0	-	-